TGA Approval

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (397093)

ARTG ID

397093

ARTG Name

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

December 6, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/d33b56f8f05e1ac1636ed39cd5e0d785.pdf

https://medical-cdn.nocode.com/drug_tga/d06bfbdd76c8880e926f60b6150e8c9a.pdf

Ingredient Name

dabrafenib mesilate

Empowering clinical research with data-driven insights and AI-powered tools.

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (397093) - TGA 批准文号 | MedPath